B (Brenda) Leeneman, MSc

Erasmus School of Health Policy & Management

Assistant professor | Health Technology Assessment (HTA)

Email: leeneman@eshpm.eur.nl

Pure profile

Work

N. S.H. Xander, B. Leeneman, A. M.C. Dingemans, W. E. Fiets, W. K. de Jong, N. E.M. Uyl, A. N.M. Wymenga, A. K.L. Reyners & C. A. Uyl-de Groot (2024) - Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not? - European Journal of Cancer, 209 - doi: 10.1016/j.ejca.2024.114262 - [link]
Olivier J. van Not, Alfons J.M. van den Eertwegh, Hilde Jalving, Manja Bloem, John B. Haanen, Rozemarijn S. van Rijn, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem de Groot J W B, Geke A.P. Hospers, Ellen Kapiteijn, Brenda Leeneman, Piersma D, Marion Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil G, Michel W.J.M. Wouters, Willeke A.M. Blokx & Karijn P.M. Suijkerbuijk (2024) - Long-Term Survival in Patients With Advanced Melanoma - JAMA network open, 7 (8) - doi: 10.1001/jamanetworkopen.2024.26641 - [link]
Brenda Leeneman, Nicolas S.H. Xander, W. Edward Fiets, Wouter K. de Jong, Nathalie E.M. Uyl, A. N.Machteld Wymenga, An K.L. Reyners & Carin A. Uyl-de Groot (2024) - Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness - European Journal of Cancer, 202 - doi: 10.1016/j.ejca.2024.114002 - [link]
Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen-Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl-de Groot & Frederick W. Thielen (2023) - Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease - European Journal of Haematology, 111 (2), 240-246 - doi: 10.1111/ejh.13987 - [link]
M. G. Franken, B. Leeneman, M. J.B. Aarts, A. C.J. van Akkooi, F. W.P.J. van den Berkmortel, M. J. Boers-Sonderen, A. J.M. van den Eertwegh, J. W.B. de Groot, G. A.P. Hospers, E. Kapiteijn, D. Piersma, R. S. van Rijn, K. P.M. Suijkerbuijk, A. A.M. van der Veldt, H. M. Westgeest, M. W.J.M. Wouters, J. B.A.G. Haanen & C. A. Uyl-de Groot (2021) - Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs - ESMO Open, 6 (6) - doi: 10.1016/j.esmoop.2021.100320 - [link]
Brenda Leeneman (2021) - Evidence-based decision making on drug reimbursement in melanoma: Using real-world evidence to complement evidence from randomized controlled trials
Brenda Leeneman, Kay Schreuder, Carin A. Uyl - de Groot, Alexander C.J. van Akkooi, John B.A.G. Haanen, Marlies Wakkee, Margreet G. Franken & Marieke W.J. Louwman (2021) - Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study - European Journal of Cancer, 2021 (154), 111-119 - doi: 10.1016/j.ejca.2021.06.007 - [link]
Brenda Leeneman, Hedwig M. Blommestein, Veerle M.H. Coupé, Mathijs P. Hendriks, Wim H.J. Kruit, Peter W. Plaisier, Serge Van Ruth, Albert J. Ten Tije, Michel W.J.M. Wouters, Margreet G. Franken & Carin A. Uyl-De Groot (2021) - Real-world healthcare costs of localized and regionally advanced cutaneous melanoma in the Netherlands - Melanoma Research, 31 (3), 249-257 - doi: 10.1097/cmr.0000000000000732 - [link]
Brenda Leeneman, Carin Uyl - de Groot, MJB Aarts, ACJ Akkooi, F van den Berkmortel, AJM Van den Eertwegh, JW de Groot, KH Herbschleb, JJ van der Hoeven, GA Hospers, E Kapiteijn, D Piersma, RS van Rijn, KPM Suijkerbuijk, AJ ten Tije, Astrid van der Veldt, G Vreugdenhil, M Wouters, J Haanen & Margreet Franken (2020) - Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs - Cancers, 12 (4) - doi: 10.3390/cancers12041003
Margreet Franken, Brenda Leeneman, Maria Gheorghe, Carin Uyl - de Groot, JBAG Haanen & Pieter van Baal (2019) - A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma - European Journal of Cancer, 123, 58-71 - doi: 10.1016/j.ejca.2019.08.032 - [link]